ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by metabolic reprogramming of oxLDL lipophagy

Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome that elevates the risk of hepatocellular carcinoma (HCC). Although alteration of lipid metabolism has been increasingly recognized as a hallmark of cancer cells, the deregulated metabolic modulation of H...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuan, Yang, Bin, Qiu, Weinan, Hao, Yajing, Zhang, Zhenxing, Yang, Bo, Li, Nan, Cheng, Shuqun, Lin, Zhangjun, Rui, Yao-cheng, Cheung, Otto K. W., Yang, Weiqin, Wu, William K. K., Cheung, Yue-Sun, Lai, Paul B. S., Luo, Jianjun, Sung, Joseph J. Y., Chen, Runsheng, Wang, Hong-Yang, Cheng, Alfred S. L., Yang, Pengyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662851/
https://www.ncbi.nlm.nih.gov/pubmed/31358770
http://dx.doi.org/10.1038/s41467-019-11274-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662851/
https://www.ncbi.nlm.nih.gov/pubmed/31358770
http://dx.doi.org/10.1038/s41467-019-11274-x

Ejemplares similares